Rare diseases
Investigational molecules
Locations
459 conditions with trials, the busiest first
1 397 trials across Europe, recruiting first
Study of IMVT-1402 in Adults with Mild to Severe Generalized Myasthenia Gravis
CzechiaStudy of iodofalan (131I) and lomustine combination therapy compared to lomustine alone in patients with first recurrent glioblastoma
AustriaStudy of brimonidine tartrate gel to prevent nerve damage in breast cancer patients receiving taxane treatment
FranceStudy of PRAX-628 to evaluate safety and effectiveness in adults with epilepsy who have focal seizures or generalized tonic-clonic seizures
GermanyStudy of Elsunersen in Children with SCN2A Developmental and Epileptic Encephalopathy to Reduce Seizures
GermanyStudy of alteplase and tenecteplase for intravenous thrombolysis in patients with ischemic stroke who are taking direct oral anticoagulants
AustriaStudy of levodopa and carbidopa treatment for patients with neurodevelopmental disorder caused by CTNNB1 gene mutation
FranceStudy of intrathecal S230815 to evaluate safety and effectiveness in children with KCNT1-related Developmental and Epileptic Encephalopathy
FranceStudy of tarlatamab and temozolomide combination treatment in adolescents and adults with high grade brain tumors
FranceStudy comparing remibrutinib and ocrelizumab in patients with relapsing multiple sclerosis who switch from ocrelizumab treatment
BelgiumStudy of hypertonic saline solution and mannitol to improve recovery in patients with traumatic brain injury and high risk of intracranial hypertension
FranceStudy of MK-2214 to slow disease progression in people with early Alzheimer's disease
BelgiumThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
